Spark Therapeutics Stock
Your prediction
Pros and Cons of Spark Therapeutics in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Spark Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| United Therapeutics | -1.710% | 11.672% | 20.347% | 79.930% | 20.009% | 155.378% | 258.601% |
| Ionis Pharmaceuticals Inc. | 2.430% | 6.562% | -4.918% | 132.915% | -4.414% | 96.998% | 69.431% |
| Novocure Ltd | 0.710% | -5.490% | -18.320% | -42.790% | -16.771% | -82.993% | -91.633% |
News
The Quiet Retail Compounder Investors Keep Buying on Every Dip
Casey’s General Stores (NASDAQ: CASY) is a long-term retail holding that has tended to reward a buy-the-dip strategy. This company is as quality as they come, internally funding growth
Unity Software Is Falling—So Why Are Pros Getting More Bullish?
Unity Software (NYSE: U) experienced a jarring sell-off in mid-January 2026. The stock tumbled nearly 7% to close around $40.96, capping off its difficult start to 2026. For an investor looking
Why FuelCell Energy Stock Is Soaring After a Government Deal
After months of downward pressure, FuelCell Energy (NASDAQ: FCEL) has roared back to life.
Its stock price has risen more than 20% over three trading sessions ending in early December